Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [3223]

$Ficlatuzumab plus chemotherapy shows promise for the treatment of patients with relapsed/refractory acute myeloid leukaemia$

Ficlatuzumab plus chemotherapy shows promise for the treatment of patients with relapsed/refractory acute myeloid...

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma

FDA approves daratumumab and hyaluronidase-fihj with pomalidomide and dexamethasone for multiple myeloma

CNIO researchers discover a new pathway to tackle follicular lymphoma

CNIO researchers discover a new pathway to tackle follicular lymphoma

Protein appears to prevent tumour cells from spreading via blood vessels

Protein appears to prevent tumour cells from spreading via blood vessels

New imaging method tracks cancer treatment efficacy in preclinical studies

New imaging method tracks cancer treatment efficacy in preclinical studies

FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukaemia and lymphoma

FDA approves asparaginase erwinia chrysanthemi (recombinant) for leukaemia and lymphoma

Cell-based immunotherapy shows promise against melanoma

Cell-based immunotherapy shows promise against melanoma

Two studies by CU Cancer Center researchers explore link between inflammation and leukaemia

Two studies by CU Cancer Center researchers explore link between inflammation and leukaemia

Researchers study potential new CAR-T cell therapy for multiple myeloma

Researchers study potential new CAR-T cell therapy for multiple myeloma

Novel risk score for predicting blood cancer relapse

Novel risk score for predicting blood cancer relapse

More from ecancer